Abbott Laboratories (ABT) just introduced Ensure Max Protein 3-in-1 Muscle Support, a powder that combines protein, creatine ...

In a nationwide cohort of more than 2.5 million average-risk adults, researchers found that completing mt-sDNA screening was associated with an approximately 54% lower adjusted incidence rate of ...

Shares of Abbott Laboratories (ABT) have seen a small negative price reaction in response to a larger deal for its smaller diagnostic peer Exact Sciences Corporation (EXAS), taking place at a revenue ...

Abbott Laboratories (NYSE:ABT) introduced Ensure Max Protein 3-in-1 Muscle Support, a combined protein, creatine, and HMB ...

Key collaborations enable Abbott to increase its global presence and accessibility to patients who haven't used CGMs before, potentially resulting in a 15% CAGR in FreeStyle Libre sales by 2028. With ...

Abbott, a global healthcare leader, announced today that the Cologuard Plus® test has received CE Mark under the European Union's In ...

The healthcare conglomerate Abbott Laboratories said on Thursday it would buy Exact Sciences, makers of the at-home colon cancer test Cologuard, for roughly $21 billion. The deal appears to be the ...

Follow Abbott Laboratories as investors assess medical devices and diagnostics, the current catalyst, execution risks and the company evidence that may shape its next market move.

Abbott has scored yet another Emergency Use Authorization for rapid coronavirus testing – this one, named BinaxNOW COVID-19 Ag Card, come in the form of a card and can provide results in 15 minutes.